Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.

The global Psoriasis Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Therapeutics.

Report Scope

The Psoriasis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Psoriasis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Psoriasis Therapeutics Market Report

Report Metric	Details
Report Name	Psoriasis Therapeutics Market
CAGR	5%
Segment by Type	TNF Inhibitors PDE4 Inhibitors Interleukin Blockers Others
Segment by Application	Oral Parenteral Topical
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, GlaxoSmithKline plc, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, G & W Laboratories Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriasis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psoriasis Therapeutics Market report?

Ans: The main players in the Psoriasis Therapeutics Market are Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, GlaxoSmithKline plc, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, G & W Laboratories Inc.

What are the Application segmentation covered in the Psoriasis Therapeutics Market report?

Ans: The Applications covered in the Psoriasis Therapeutics Market report are Oral, Parenteral, Topical

What are the Type segmentation covered in the Psoriasis Therapeutics Market report?

Ans: The Types covered in the Psoriasis Therapeutics Market report are TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 TNF Inhibitors

1.2.3 PDE4 Inhibitors

1.2.4 Interleukin Blockers

1.2.5 Others

1.3 Market by Application

1.3.1 Global Psoriasis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Oral

1.3.3 Parenteral

1.3.4 Topical

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Psoriasis Therapeutics Market Perspective (2019-2030)

2.2 Psoriasis Therapeutics Growth Trends by Region

2.2.1 Global Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Psoriasis Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Psoriasis Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Psoriasis Therapeutics Market Dynamics

2.3.1 Psoriasis Therapeutics Industry Trends

2.3.2 Psoriasis Therapeutics Market Drivers

2.3.3 Psoriasis Therapeutics Market Challenges

2.3.4 Psoriasis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Psoriasis Therapeutics Players by Revenue

3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue

3.4 Global Psoriasis Therapeutics Market Concentration Ratio

3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2023

3.5 Psoriasis Therapeutics Key Players Head office and Area Served

3.6 Key Players Psoriasis Therapeutics Product Solution and Service

3.7 Date of Enter into Psoriasis Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriasis Therapeutics Breakdown Data by Type

4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2025-2030)

5 Psoriasis Therapeutics Breakdown Data by Application

5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Psoriasis Therapeutics Market Size (2019-2030)

6.2 North America Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Psoriasis Therapeutics Market Size by Country (2019-2024)

6.4 North America Psoriasis Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Psoriasis Therapeutics Market Size (2019-2030)

7.2 Europe Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Psoriasis Therapeutics Market Size by Country (2019-2024)

7.4 Europe Psoriasis Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Psoriasis Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Psoriasis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Psoriasis Therapeutics Market Size (2019-2030)

9.2 Latin America Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Psoriasis Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Psoriasis Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Psoriasis Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Psoriasis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astellas Pharma Inc.

11.1.1 Astellas Pharma Inc. Company Detail

11.1.2 Astellas Pharma Inc. Business Overview

11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction

11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)

11.1.5 Astellas Pharma Inc. Recent Development

11.2 AstraZeneca plc

11.2.1 AstraZeneca plc Company Detail

11.2.2 AstraZeneca plc Business Overview

11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction

11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2019-2024)

11.2.5 AstraZeneca plc Recent Development

11.3 Boehringer Ingelheim GmbH

11.3.1 Boehringer Ingelheim GmbH Company Detail

11.3.2 Boehringer Ingelheim GmbH Business Overview

11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction

11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2019-2024)

11.3.5 Boehringer Ingelheim GmbH Recent Development

11.4 F. Hofffmann-La Roche

11.4.1 F. Hofffmann-La Roche Company Detail

11.4.2 F. Hofffmann-La Roche Business Overview

11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction

11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2019-2024)

11.4.5 F. Hofffmann-La Roche Recent Development

11.5 GlaxoSmithKline plc

11.5.1 GlaxoSmithKline plc Company Detail

11.5.2 GlaxoSmithKline plc Business Overview

11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction

11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2019-2024)

11.5.5 GlaxoSmithKline plc Recent Development

11.6 Merck & Co., Inc.

11.6.1 Merck & Co., Inc. Company Detail

11.6.2 Merck & Co., Inc. Business Overview

11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction

11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)

11.6.5 Merck & Co., Inc. Recent Development

11.7 Valeant Pharmaceuticals International, Inc.

11.7.1 Valeant Pharmaceuticals International, Inc. Company Detail

11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview

11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction

11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)

11.7.5 Valeant Pharmaceuticals International, Inc. Recent Development

11.8 Biocon Limited

11.8.1 Biocon Limited Company Detail

11.8.2 Biocon Limited Business Overview

11.8.3 Biocon Limited Psoriasis Therapeutics Introduction

11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2019-2024)

11.8.5 Biocon Limited Recent Development

11.9 Eli Lilly and Company

11.9.1 Eli Lilly and Company Company Detail

11.9.2 Eli Lilly and Company Business Overview

11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction

11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2019-2024)

11.9.5 Eli Lilly and Company Recent Development

11.10 G & W Laboratories Inc.

11.10.1 G & W Laboratories Inc. Company Detail

11.10.2 G & W Laboratories Inc. Business Overview

11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction

11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)

11.10.5 G & W Laboratories Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astellas Pharma Inc

Astrazeneca plc

Boehringer Ingelheim GmbH

F. Hofffmann-La Roche

GlaxoSmithKline PLC

Merck& Co. Inc

Valeant Pharmaceuticals International Inc

Biocon Ltd.

Eli Lilly and Company

G & W Laboratories Inc.

List of Tables

Table 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of TNF Inhibitors

Table 3. Key Players of PDE4 Inhibitors

Table 4. Key Players of Interleukin Blockers

Table 5. Key Players of Others

Table 6. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Psoriasis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Psoriasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Psoriasis Therapeutics Market Share by Region (2019-2024)

Table 10. Global Psoriasis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Psoriasis Therapeutics Market Share by Region (2025-2030)

Table 12. Psoriasis Therapeutics Market Trends

Table 13. Psoriasis Therapeutics Market Drivers

Table 14. Psoriasis Therapeutics Market Challenges

Table 15. Psoriasis Therapeutics Market Restraints

Table 16. Global Psoriasis Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Psoriasis Therapeutics Market Share by Players (2019-2024)

Table 18. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2023)

Table 19. Ranking of Global Top Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Psoriasis Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Psoriasis Therapeutics Product Solution and Service

Table 23. Date of Enter into Psoriasis Therapeutics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Psoriasis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Psoriasis Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Psoriasis Therapeutics Revenue Market Share by Application (2019-2024)

Table 31. Global Psoriasis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Psoriasis Therapeutics Revenue Market Share by Application (2025-2030)

Table 33. North America Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Psoriasis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Astellas Pharma Inc. Company Detail

Table 49. Astellas Pharma Inc. Business Overview

Table 50. Astellas Pharma Inc. Psoriasis Therapeutics Product

Table 51. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 52. Astellas Pharma Inc. Recent Development

Table 53. AstraZeneca plc Company Detail

Table 54. AstraZeneca plc Business Overview

Table 55. AstraZeneca plc Psoriasis Therapeutics Product

Table 56. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 57. AstraZeneca plc Recent Development

Table 58. Boehringer Ingelheim GmbH Company Detail

Table 59. Boehringer Ingelheim GmbH Business Overview

Table 60. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product

Table 61. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 62. Boehringer Ingelheim GmbH Recent Development

Table 63. F. Hofffmann-La Roche Company Detail

Table 64. F. Hofffmann-La Roche Business Overview

Table 65. F. Hofffmann-La Roche Psoriasis Therapeutics Product

Table 66. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 67. F. Hofffmann-La Roche Recent Development

Table 68. GlaxoSmithKline plc Company Detail

Table 69. GlaxoSmithKline plc Business Overview

Table 70. GlaxoSmithKline plc Psoriasis Therapeutics Product

Table 71. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 72. GlaxoSmithKline plc Recent Development

Table 73. Merck & Co., Inc. Company Detail

Table 74. Merck & Co., Inc. Business Overview

Table 75. Merck & Co., Inc. Psoriasis Therapeutics Product

Table 76. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Merck & Co., Inc. Recent Development

Table 78. Valeant Pharmaceuticals International, Inc. Company Detail

Table 79. Valeant Pharmaceuticals International, Inc. Business Overview

Table 80. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product

Table 81. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Valeant Pharmaceuticals International, Inc. Recent Development

Table 83. Biocon Limited Company Detail

Table 84. Biocon Limited Business Overview

Table 85. Biocon Limited Psoriasis Therapeutics Product

Table 86. Biocon Limited Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Biocon Limited Recent Development

Table 88. Eli Lilly and Company Company Detail

Table 89. Eli Lilly and Company Business Overview

Table 90. Eli Lilly and Company Psoriasis Therapeutics Product

Table 91. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Eli Lilly and Company Recent Development

Table 93. G & W Laboratories Inc. Company Detail

Table 94. G & W Laboratories Inc. Business Overview

Table 95. G & W Laboratories Inc. Psoriasis Therapeutics Product

Table 96. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)

Table 97. G & W Laboratories Inc. Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Psoriasis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Psoriasis Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. TNF Inhibitors Features

Figure 4. PDE4 Inhibitors Features

Figure 5. Interleukin Blockers Features

Figure 6. Others Features

Figure 7. Global Psoriasis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Psoriasis Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Oral Case Studies

Figure 10. Parenteral Case Studies

Figure 11. Topical Case Studies

Figure 12. Psoriasis Therapeutics Report Years Considered

Figure 13. Global Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Psoriasis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Psoriasis Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Psoriasis Therapeutics Market Share by Players in 2023

Figure 17. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2023

Figure 19. North America Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Psoriasis Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Psoriasis Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Psoriasis Therapeutics Market Share by Region (2019-2030)

Figure 33. China Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Psoriasis Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Psoriasis Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 48. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 50. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 51. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 52. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 53. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 54. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 55. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 56. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-16L13206

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Necrobiosis Lipoidica Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-7H13898

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Complicated Skin and Skin Structure Infections Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17N13814

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Perioral Dermatitis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22F12803

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Psoriasis Therapeutics Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-28R13138

Global Psoriasis Therapeutics Market Research Report 2024

FEATURED COMPANIES

Psoriasis Therapeutics Market Size

Psoriasis Therapeutics Market

Report Scope

Scope of Psoriasis Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Psoriasis Therapeutics Market report?

What are the Application segmentation covered in the Psoriasis Therapeutics Market report?

What are the Type segmentation covered in the Psoriasis Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS